1. Home
  2. MUX vs OBX Comparison

MUX vs OBX Comparison

Compare MUX & OBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

N/A

Current Price

$9.17

Market Cap

733.1M

ML Signal

N/A

Logo Obsidian Therapeutics Inc. Common Stock

OBX

Obsidian Therapeutics Inc. Common Stock

N/A

Current Price

$11.97

Market Cap

848.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MUX
OBX
Founded
1979
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
733.1M
848.8M
IPO Year
1994
2026

Fundamental Metrics

Financial Performance
Metric
MUX
OBX
Price
$9.17
$11.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$28.40
★ $38.67
AVG Volume (30 Days)
★ 1.3M
541.6K
Earning Date
11-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ 0.10
N/A
Revenue
★ $197,553,000.00
N/A
Revenue This Year
$19.23
N/A
Revenue Next Year
$34.88
N/A
P/E Ratio
$96.10
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.59
$9.60
52 Week High
$29.70
$39.00

Technical Indicators

Market Signals
Indicator
MUX
OBX
Relative Strength Index (RSI) 22.06 42.10
Support Level N/A $11.84
Resistance Level $20.62 $15.87
Average True Range (ATR) 0.82 1.60
MACD -0.40 -0.03
Stochastic Oscillator 0.34 43.34

Price Performance

Historical Comparison
MUX
OBX

About MUX McEwen Mining Inc.

McEwen Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. Its Other operations include: Fox Complex, Gold Bar Complex, Project Fenix, and Los Azules. The company generates its revenue from gold and silver production. Its operating segments include Canada, United States, Mexico, MSC and McEwen Copper, of which it derives maximum revenue from USA.

About OBX Obsidian Therapeutics Inc. Common Stock

Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The company's proprietary cytoDRiVE platform is versatile and allows it to leverage drug responsive domains to control protein function, with its initial focus on TIL cell therapies developed from this platform (cytoTILs). The company's flagship product candidate, OBX-115, is a novel, genetically engineered, autologous TIL cell therapy currently in a Phase 2 clinical trial for the treatment of melanoma and a Phase 1 clinical trial for the treatment of non-small cell lung cancer.

Share on Social Networks: